Page 21 - P4403.59-V44_Numark Magazine October 23 web

Lacrilube ® Golden Tote

Lubricating Eye Ointment Multi-terminal

is back has finally

Available OTC and via prescription
arrived!

It’s here, the multi-terminal functionality you were waiting for has
now been tried, tested and is ready to go!

One of the core feedback points from our members on Golden Tote
Now available was how the functionality could be more seamlessly used if it was
available on multiple PMRs within the pharmacy.
to order We’ve worked closely with our development team to build and test
this functionality within Golden Tote, and are excited to say we’ve
cracked it!

Multiple Golden Totes can now be assembled at various machines in
the pharmacy, simultaneously, helping to further improve efficiencies
and give you time back for you to interact with your patients.
This marks a significant leap in our Golden Tote proposition,
expanding the reach of this time-saving innovation to even more
members. But the intrigue doesn't end here. If you're curious to delve
deeper into the mechanics of this evolution, we invite you to take
the next step.

Arrange a consultation with our implementation team who will
happily demonstrate the system within your pharmacy, explain how
this will work specifically for your requirements, and answer any
questions you may have.
Indication: LACRILUBE is intended to lubricate and hydrate the surface of the
eye(s) and is indicated to help provide temporary relief of dryness, irritation, Get in touch to arrange your consultation via
burning, discomfort and/or any other symptoms caused by dry eye disease
(DED) or environmental factors. 1 goldentotesupport@numark-central.co.uk

PIP code: 0344739 Drug Tariff: £2.05 RRP: £4.99 For more information on Golden Tote, visit
numarknet.com/goldentote

Reference: 1. Lacrilube Instructions For Use.
This is a medical device. Always read the label and follow the instruction for use.
Adverse events should be reported.
Reporting forms and information can be found at https://
yellowcard.mhra.gov.uk or via the MHRA Yellow Card app,
available in the Google Play or Apple App Stores. Created and funded by
Adverse events should also be reported to AbbVie on GBPV@abbvie.com

Date of preparation: August 2023 UK-RFS-230006

2121

21434 Lacrilube A5 Advert June 2023 RGB_UK-RFS-230004.indd 1 31/07/2023 11:25
21434 Lacrilube A5 Advert June 2023 RGB_UK-RFS-230004.indd 1
31/07/2023 11:25